|
183
|
555
|
3qggA |
Crystal structure of the hepatitis c virus ns5b rna-dependent rna polymerase complex with (2e)-3-(4-{[(1-{[(13-cyclohexyl-6-oxo-6,7-dihydro-5h-indolo[1,2-d][1,4]benzodiazepin-10-yl)carbonyl]amino}cyclopentyl)carbonyl]amino}phenyl)prop-2-enoic acid and n-cyclopropyl-6-[(3r)-3-{[4-(trifluoromethoxy)benzyl]carbamoyl}-4-{[4-(trifluoromethoxy)phenyl]sul |
|
192
|
573
|
3q0zA |
Crystal structure of the hepatitis c virus ns5b rna-dependent rna polymerase complex with (2e)-3-(4-{[(1-{[(13-cyclohexyl-6-oxo-6,7-dihydro-5h-indolo[1,2-d][1,4]benzodiazepin-10-yl)carbonyl]amino}cyclopentyl)carbonyl]amino}phenyl)prop-2-enoic acid |
|
42
|
182
|
3p8nA |
Crystal structure of hcv ns3/ns4a protease complexed with bi 201335 |
|
38
|
182
|
3p8oA |
Crystal structure of hcv ns3/ns4a protease complexed with des-bromine analogue of bi 201335 |
|
38
|
174
|
3oypA |
Hcv ns3/4a in complex with ligand 3 |
|
207
|
645
|
3o8dA |
Visualizing atp-dependent rna translocation by the ns3 helicase from hcv |
|
219
|
645
|
3o8bA |
Visualizing atp-dependent rna translocation by the ns3 helicase from hcv |
|
0
|
9
|
3mrgP |
Crystal structure of mhc class i hla-a2 molecule complexed with hcv ns3-1073-1081 nonapeptide |
|
0
|
9
|
3mrhP |
Crystal structure of mhc class i hla-a2 molecule complexed with hcv ns3-1073-1081 nonapeptide n3s variant |
|
203
|
563
|
3mwwA |
Crystal structure of hcv ns5b polymerase |
|
202
|
562
|
3mf5A |
Hepatitis c virus polymerase ns5b (bk) with amide bioisostere thumb site inhibitor |
|
0
|
9
|
3mrjP |
Crystal structure of mhc class i hla-a2 molecule complexed with hcv ns3-1073-1081 nonapeptide v5m variant |
|
199
|
563
|
3mwvA |
Crystal structure of hcv ns5b polymerase |
|
49
|
197
|
3m5mA |
Avoiding drug resistance against hcv ns3/4a protease inhibitors |
|
48
|
200
|
3m5nA |
Crystal structure of hcv ns3/4a protease in complex with n-terminal product 4b5a |
|
50
|
198
|
3m5oA |
Crystal structure of hcv ns3/4a protease in complex with n-terminal product 5a5b |
|
50
|
198
|
3m5lA |
Crystal structure of hcv ns3/4a protease in complex with itmn-191 |
|
199
|
563
|
3lkhA |
Inhibitors of hepatitis c virus polymerase: synthesis and characterization of novel 6-fluoro-n-[2-hydroxy-1(s)-benzamides |
|
42
|
181
|
3kn2A |
Hcv ns3 protease domain with ketoamide inhibitor |
|
36
|
154
|
3kf2A |
The hcv ns3/ns4a protease apo structure |
|
43
|
178
|
3keeA |
Hcv ns3/ns4a complexed with non-covalent macrocyclic compound tmc435 |
|
200
|
562
|
3igvA |
Crystal structure of hcv ns5b polymerase with a novel monocyclic dihydro-pyridinone inhibitor |
|
212
|
566
|
3i5kA |
Crystal structure of the ns5b polymerase from hepatitis c virus (hcv) strain jfh1 |
|
206
|
563
|
3hkwA |
Hcv ns5b genotype 1a in complex with 1,5 benzodiazepine inhibitor 6 |
|
200
|
564
|
3hkyA |
Hcv ns5b polymerase genotype 1b in complex with 1,5 benzodiazepine 6 |
|
212
|
563
|
3hvoA |
Structure of the genotype 2b hcv polymerase bound to a nni |
|
207
|
562
|
3h5sA |
Hepatitis c virus polymerase ns5b with saccharin inhibitor |
|
208
|
563
|
3h98A |
Crystal structure of hcv ns5b 1b with (1,1-dioxo-2h-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyrimidine derivative |
|
206
|
562
|
3gynA |
Crystal structure of hcv ns5b polymerase with a novel monocyclic dihydropyridinone inhibitor |
|
205
|
562
|
3h59A |
Hepatitis c virus polymerase ns5b with thiazine inhibitor 2 |
|
209
|
563
|
3h5uA |
Hepatitis c virus polymerase ns5b with saccharin inhibitor 1 |
|
208
|
563
|
3gszA |
Structure of the genotype 2b hcv polymerase |
|
208
|
562
|
3h2lA |
Crystal structure of hcv ns5b polymerase in complex with a novel bicyclic dihydro-pyridinone inhibitor |
|
204
|
562
|
3g86A |
Hepatitis c virus polymerase ns5b (bk 1-570) with thiazine inhibitor |
|
197
|
563
|
3golA |
Hcv ns5b polymerase in complex with 1,5 benzodiazepine inhibitor (r)-11d |
|
203
|
563
|
3gnwA |
Hcv ns5b polymerase in complex with 1,5 benzodiazepine inhibitor 4c |
|
203
|
563
|
3gnvA |
Hcv ns5b polymerase in complex with 1,5 benzodiazepine inhibitor 1b |
|
206
|
562
|
3fqkA |
Hepatitis c virus polymerase ns5b (bk 1-570) with hcv-796 inhibitor |
|
30
|
160
|
3fqqA |
Crystal structure of a novel dimeric form of hcv ns5a domain i protein |
|
208
|
566
|
3fqlA |
Hepatitis c virus polymerase ns5b (con1 1-570) with hcv-796 inhibitor |
|
208
|
562
|
3frzA |
Crystal structure of hcv ns5b rna polymerase in complex with pf868554 |
|
31
|
160
|
3fqmA |
Crystal structure of a novel dimeric form of hcv ns5a domain i protein |
|
0
|
22
|
3eydB |
Structure of hcv ns3-4a protease with an inhibitor derived from a boronic acid |
|
41
|
181
|
3eydA |
Structure of hcv ns3-4a protease with an inhibitor derived from a boronic acid |
|
201
|
562
|
3e51A |
Crystal structure of hcv ns5b polymerase with a novel pyridazinone inhibitor |
|
204
|
562
|
3d5mA |
Crystal structure of hcv ns5b polymerase with a novel pyridazinone inhibitor |
|
202
|
562
|
3cvkA |
Crystal structure of hcv ns5b polymerase with a novel pyridazinone inhibitor |
|
203
|
562
|
3d28A |
Crystal structure of hcv ns5b polymerase with a novel benzisothiazole inhibitor |
|
204
|
563
|
3csoA |
Hcv polymerase in complex with a 1,5 benzodiazepine inhibitor |
|
199
|
562
|
3cwjA |
Crystal structure of hcv ns5b polymerase with a novel pyridazinone inhibitor |
